Dyad Medical Selected for MassChallenge Boston 2019 Accelerator

May 15, 2019

Dyad Medical joins global network of startups

Boston, Massachusetts, May 15, 2019 – Dyad Medical, deep learning imaging analytics company, today announced that it was selected to participate in the 2019 MassChallenge Boston accelerator program. Rigorously selected by a community of close to 200 expert judges, Dyad Medical represents the top 9% of applications from around the world, including 61 countries and 25 U.S. states.

Through a global network of zero-equity accelerators, MassChallenge identifies the world’s highest-impact, highest-potential startups and helps them successfully launch and grow. As part of the 2019 cohort, Dyad Medical will have unrivaled access to expert mentorship, top corporate partners, and more than 20,000 square-feet of co-working space – all at zero cost and for zero equity. Dyad Medical will also engage in evidence-based curriculum, which has been designed to address key challenges throughout each phase of the early-stage lifecycle, including discovery, development, deployment, and distribution. At the close of the program, startups will compete for more than $1M in cash prizes at the 2019 MassChallenge Boston Awards held on October 24.

“We are on a mission to provide a cardiologist an insight with every single scan they perform, regardless of the modality used and what part of the heart they scan,” says Dr. Ronny Shalev, co-founder and CEO of Dyad Medical. “While we are clear on our goal to provide universal access to expert-level diagnosis by teaching computers to automatically analyze medical images, we are grateful that others understand where we’re going and believe in our mission. Our thanks to MassChallenge for supporting us!”

About Dyad Medical
Dyad Medical develops clinical applications using artificial intelligence aimed at enabling doctors to more efficiently and effectively interpret medical image content. Within the digital diagnostics arena, Dyad Medical’s core focus is in Cardiovascular (more people die as a result of cardiovascular disease than all types of cancer combined) and Neuroradiology image analytics. Dyad Medical’s solutions will be offered in two spaces:
1. Research: where image interpretation is done off-line, post-image-acquisition.
2. In the clinic, to support treatment decisions.

About MassChallenge
MassChallenge is a global network of zero-equity startup accelerators. Headquartered in the United States with locations in Boston, Israel, Mexico, Rhode Island, Switzerland, and Texas, MassChallenge is committed to strengthening the global innovation ecosystem by supporting high-potential startups across all industries, from anywhere in the world. To date, more than 1,900 MassChallenge alumni have raised more than $4 billion in funding, generated more than $2.5 billion in revenue, and created more than 120,000 total jobs.